Abstract
Maintenance of normal tissue cell number requires a net balance between the rate of cell division and the rate of cell death. The uncontrolled growth characteristic of both benign and metastatic tumors may be due to either an increase in the rate of proliferation or a decrease in the rate of cell death, or both (Williams 1991). Cell death can be classified into one of two categories: necrosis, the result of tissue insult or injury; and apoptosis, or active cell death (ACD), a process of active cellular self-destruction. ACD is an asynchronous process consisting of a series of distinct steps which are common to epithelial cells of the prostate, mammary gland, liver, and many other tissues (Bursch et al. 1990). A schematic representation of the morphology and biochemistry of ACD is shown in Fig. 1. The first visible stage of ACD in regressing mammary gland involves disruption of the cytoskeleton and condensation of intermediate filaments around the nucleus. During this stage, loss of cell to cell contacts results in the release of dying cells from the basement membrane in vivo or rounding up and detachment of adherent cells in vitro. The early apoptotic cell thus lies above the plane of the monolayer and is characterized by cytoplasmic condensation. Chromatin condensation occurs simultaneously, producing the hyperchromatic, pyknotic nucleus, which then separates into discrete masses of condensed chromatin. In some, but not all, forms of ACD, cleavage of DNA into large (50–300-kbp) fragments and further degradation into 200-bp fragments, characteristic of a nucleosome ladder, can be demonstrated (Oberhammer et al. 1993). Finally, the cell itself fragments into a number of membrane-bound vesicles called apoptotic bodies, some of which contain chromatin. In vitro, apoptotic cells and bodies can be recovered in the media, whereas in vivo, these are removed by phagocytic macrophages.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe J, Nakano T, Nishii Y, Matsumoto T, Ogata E, Ikeda K (1992) A novel vitamin D3 analog, 22-oxa-1,25 dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 129: 832–837
Armstrong DK, Isaacs JT, Ottaviano YL, Davidson NE (1992) Programmed cell death in an estrogen independent human breast cancer cell line, MDAMB-468. Cancer Res 52: 3418–3424
Berger U, Wilson P, McClelland RA, Colston K, Haussier MR, Pike W, Coombes RC (1987) Immunocytochemical detection of 1,25-dihydroxyvitamin D3 receptor in breast cancer. Cancer Res 47: 6793–6799
Bursch W, Paffe S, Putz B, Barthel G, Schulte-Hermann R (1990) Determination of the length of the histological stages of apoptosis in normal liver and altered hepatic foci of rats. Carcinogenesis 11: 847–853
Cho-Chung YS, Gullino PM (1973) Mammary tumor regression V. Role of acid ribonuclease and cathepsin. J Biol Chem 248: 4743–4749
Chouvet C, Berger U, Coombes RC (1986) 1,25 Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 24: 373–376
Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skilleter DN (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286: 331–334
Colston K, Berger U, Wilson P, Hadcocks L, Naeem I, Earl HM, Coombes RC (1988) Mammary gland 1,25-dihydroxyvitamin D3 receptor content during pregnancy and lactation. Mol Cell Endocrinol 60: 15–22
Colston K, Chander SK, Mackay AG, Coombes RC (1992) Effects of synthetic vitamin D analogs on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 44: 693–702
Demirpence E, Balaguer P, Trousse F, Nicolas JC, Pons M, Gagner D (1994) Antiestrogenic effects of all trans retinoic acid and 1,25 dihydroxyvitamin D in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms. Cancer Res 54: 1458–1464
Eisman J, Sutherland RL, McMenemy ML, Fragonas JC, Musgrove EA, Pang G (1989) Effects of 1,25-dihydroxyvitamin D3 on cell cycle kinetics of T47D human breast cancer cells. J Cell Physiol 138: 611–616
Frampton RJ, Omond SA, Eisman JA (1983) Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res 43: 44434447
Guenette RS, Corbeil H, Leger J, Wong K, Mezl V, Mooibroek M, Tenniswood M (1994) Induction of gene expression during involution of the lactating mammary gland of the rat. J Mol Endocrinol 12: 47–60
Jeng MH, Jordan VC (1991) Growth stimulation and differential regulation of transforming growth factor-beta 1 (TGFB1), TGFB2 and TGFB3 messenger RNA levels by norethidrone in MCF-7 human breast cancer cells. Mol Endocrinol 5: 1120–1128
Kim H, Abdelkader N, Katz M, McLane JA (1992) 1,25-Dihydroxyvitamin D3 enhances antiproliferative effect and transcription of TGF-beta on human keratinocytes in culture. J Cell Physiol 151: 579–587
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynyck R, Dickson RB (1987) Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417–428
Kobayashi T, Hashimoto K, Yoshikawa K (1993) Growth inhibition of human keratinocytes by 1,25-Dihydroxyvitamin D3 is linked to dephosphorylation of retinoblastoma gene product. Biochem Biophys Res Commun 196: 487–493
Kyprianou N, English H, Davidson N, Isaacs J (1991) Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162–166
Lanzerotti RH, Gullino PM (1972) Activities and quantities of lysosomal enzymes during mammary tumor regression. Cancer Res 32: 2679–2685
Martikainen P, Kyprianou N, Isaacs JT (1990) Effect of transforming growth factor 131 on proliferation and death of rat prostatic cells. Endocrinology 127: 2963–2968
Miller TE, Beausang LA, Meneghini N, Lidgard G (1994) Cell death and nuclear matrix proteins. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 357–376
Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, Schulte-Hermann R (1991) Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. Cancer Res 51: 2478–2485
Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR, Sikorska M (1993) Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal degradation EMBO J 12: 3679–3684
Osborne CK, Boldt DH, Clark GM, Trent JM (1985) Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early Gi phase. Cancer Res 43: 3583–3585
Pilarsky C, Haase W, Koch-Brandt C (1993) Stable expression of gp80 (TRPM-2, clusterin), a secretory protein implicated in programmed cell death, in transfected BHK-21 cells. Biochim Biophys Acta 1179: 306–310
Rotello RJ, Lieberman RC, Purchio AF, Gerschenson LE (1991) Coordinated regulation of apoptosis and cell proliferation by transforming growth factor beta 1 in cultured uterine epithelial cells. Proc Natl Acad Sci USA 88: 3412–3415
Sahota SS, Edgar AJ, Colston K, Coombes RC (1991) Analysis of 1,25-dihydroxyvitamin D3 mRNA in human breast cancer tissues by polymerase chain reaction and in rat mammary tumours by Northern blots. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D: gene regulation, structure-function analysis and clinical application. Proceedings of the 8th workshop on vitamin D, 5–10 July 1991, Paris, France. De Gruyter, Berlin, pp 459–460
Tenniswood M, Guenette RS, Lakins J, Mooibroek M, Wong P, Welsh JE (1992) Active cell death in hormone dependent tissues. Cancer Metastasis Rev 11: 197–220
Tenniswood M, Taillefer D, Lakins J, Guenette RS, Mooibroek M, Daehlin L, Welsh JE (1994) Control of gene expression during apoptosis in hormone-dependent tissues. In: Tomei LD, Cope FO (eds) Apoptosis II: the molecular basis of apoptosis in disease. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp 283–311
Urban J, Parczyk K, Leutz A, Kayne M, Kondor-Kock C (1987) Constitutive apical secretion of an 80-kD sulfated glycoprotein complex in the polarized epithelial Madin Darby canine kidney cell line. J Cell Biol 105: 2735–2743
Walker PR, Kwast-Welfeld J, Gourdeau H, Leblanc J, Neugebauer W, Sikorska M (1993) Relationship between apoptosis and the cell cycle in lymphocytes: roles of protein kinase C, tyrosine phosphorylation and API. Exp Cell Res 207: 142–151
Warri AM, Huovinen RL, Laine AM, Martikainen PM, Harkonen PL (1993) Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412–1418
Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65: 1097–1098
Yang CH, Lambie EJ, Snyder M (1991) NUMA: an unusually long coiled-coil related protein in mammalian nucleus. J Cell Biol 116: 1303–1317
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Simboli-Campbell, M., Welsh, J. (1995). 1,25 Dihydroxyvitamin D3: Coordinate Regulator of Active Cell Death and Proliferation in MCF-7 Breast Cancer Cells. In: Tenniswood, M., Michna, H. (eds) Apoptosis in Hormone-Dependent Cancers. Ernst Schering Research Foundation Workshop, vol 14. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03122-3_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-03122-3_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-03124-7
Online ISBN: 978-3-662-03122-3
eBook Packages: Springer Book Archive